AILIS Care
Breast Cancer Prediction Technology
Breast Cancer Prediction Technology
AILIS Care is a pioneering startup in the field of AI, Health Care, and Medical Devices. Founded in 2016 and headquartered in Poland, the company focuses on breast cancer prediction technology. AILIS combines Dynamic Parametric Imaging, artificial intelligence, and telemedicine to immediately detect symptoms of breast cancer and estimate the risk of developing the illness.
The latest investment of $185.00K in the form of a grant was received on 20 December 2021 from the Polish Agency for Enterprise Development. AILIS is committed to providing women with dense breasts access to efficient and comfortable testing based on imaging that detects early symptoms of breast cancer. The company's vision is to guarantee comprehensive care for women in terms of monitoring their health.
AILIS prides itself on its team of experts and specialists who share common values and principles. Their mission is not only to protect the health of millions of women in an honest, responsible, and respectful way, but also to never lose their passion for science. AILIS aims to develop authentic technology and services that will become synonymous with protectiveness.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $185.00K | 1 |
|
20 Dec 2021 |
| Seed Round | $1.62M | 2 | Business Angel, National Center for Research & Development | 01 Dec 2020 |
| Pre Seed Round | $1.22M | 2 | Business Angel, National Center for Research & Development | 01 Jan 2018 |
| Pre Seed Round | $405.00K | - | 01 Jan 2016 |
No recent news or press coverage available for AILIS Care.
We care about your data, and we'd love to use cookies make your experience better.
